[Recent findings in the use of 1st and 2nd generation hypoglycemic sulfonamides]
- PMID: 4631325
- DOI: 10.1007/BF01467758
[Recent findings in the use of 1st and 2nd generation hypoglycemic sulfonamides]
Similar articles
-
[Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].Arzneimittelforschung. 1974 Mar;24(0):418-25. Arzneimittelforschung. 1974. PMID: 4211557 German. No abstract available.
-
[Studies on dose-response relationship of various sulfonylurea derivatives of the old and the new generation with further hints to extrapancreatic mechanisms of decreasing blood sugar].Arzneimittelforschung. 1972 Dec;22:Suppl 12A:2203. Arzneimittelforschung. 1972. PMID: 4198968 German. No abstract available.
-
[The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].Dtsch Med Wochenschr. 1974 Mar 1;99(9):385-8. doi: 10.1055/s-0028-1107768. Dtsch Med Wochenschr. 1974. PMID: 4208186 Clinical Trial. German. No abstract available.
-
[Current pathophysiological and clinical aspects of the mode of action of blood glucose lowering sulfonamides].Acta Diabetol Lat. 1969 Sep;6 Suppl 1:477-502. Acta Diabetol Lat. 1969. PMID: 4906024 Review. Multiple languages. No abstract available.
-
Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?Drugs. 1971;1(2):109-15. doi: 10.2165/00003495-197101020-00001. Drugs. 1971. PMID: 4999930 Review. No abstract available.
Cited by
-
[Clinical pharmacology of two new oral antidiabetics of the sulfonamide type (author's transl)].Klin Wochenschr. 1977 Jul 15;55(14):695-703. doi: 10.1007/BF01478836. Klin Wochenschr. 1977. PMID: 895007 Clinical Trial. German.
-
Dose-response relationships of tolbutamide and glibenclamide in diabetes mellitus.Eur J Clin Pharmacol. 1974 Aug 23;7(5):321-30. doi: 10.1007/BF00558200. Eur J Clin Pharmacol. 1974. PMID: 4213593 Clinical Trial. No abstract available.